Skip to main content

Benkowitz Michael's Form 4 filing

United Therapeutics Corp (UTHR) · filed Feb 18, 2026

Accession no.
0001673232-26-000010
Filed
Feb 18, 2026
Trade date
Feb 17, 2026
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $10.8M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Benkowitz MichaelCIK 0001673232Officer (PRESIDENT AND COO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 17, 2026Common StockMOption exerciseAcquired+14,625$117.76+$1,722,24014,625Indirect
Feb 17, 2026Common StockSSaleDisposed−14,625$480.75−$7,030,968.750Indirect
Feb 17, 2026Common StockMOption exerciseAcquired+7,875$146.03+$1,149,986.257,875Indirect
Feb 17, 2026Common StockSSaleDisposed−7,875$480.75−$3,785,906.250Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 17, 2026Common StockMOption exerciseDisposed−14,625$0.00$09,375Indirect
Feb 17, 2026Common StockMOption exerciseDisposed−7,875$0.00$05,065Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)